Although phenotypic studies of GPD1 mutations have focused on dyslipidemia and secondary hepatic metabolic disorders, the clinical features of patients reported by Dionisi-Vici et al. were slightly different from other reported cases. This evidence concerns the gene GPD1 and metabolic syndrome.